Morria Biopharmaceuticals PLC

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Morria Biopharmaceuticals PLC
TickerAKTX
CIK #0001541157
CUSIP00972G207
SectorLife Sciences - Pharmaceutical Preparations
Address53 Davies Street, London, W1K 5JH
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Akari Therapeutics PLC 2025-10-24 6.2 M Exemption: 506(b) · Duration: One year or less · Commission: $180,000 · Revenue: Decline to Disclose
Celsus Therapeutics PLC 2013-09-30 12.5 M Exemption: 506(c) · Duration: One year or less · Commission: $876,136 · Revenue: No Revenues
Morria Biopharmaceuticals PLC 2013-02-01 0.9 M Exemption: 506 · Remaining: $9,069,000 · Duration: One year or less · Commission: $74,480 · Revenue: No Revenues
CIK Filing 2011 - 2026
[0001541157] 10-K
[0001541157] 10-Q
[0001541157] 3
[0001541157] 4
[0001541157] 6-K
[0001541157] 8-K
[0001541157] D
[0001541157] SC 13D
[0001541157] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
MMCAP International Inc SPC Akari Therapeutics PLC [2026-06-08] 0.0
Huh Hoyoung Akari Therapeutics PLC [2025-02-14] 0.0
Theofilos Charles Steve Akari Therapeutics PLC [2024-06-18] 0.99
Patel Samir Rashmikant Akari Therapeutics PLC [2024-06-07] 14.5
Aspire Capital Fund LLC Akari Therapeutics PLC [2020-07-02] 19.89
Patel Samir Rashmikant Akari Therapeutics PLC [2019-10-04] 7.1
Shigeta Yasumitsu Akari Therapeutics PLC [2019-08-19] 7.94
RPC Pharma Ltd Akari Therapeutics PLC [2015-09-29] 61.0
Flynn James E Akari Therapeutics PLC [2015-09-21] 4.89
Boxer Capital LLC Celsus Therapeutics PLC [2015-08-28] 0.0
Cormorant Global Healthcare Master Fund LP Celsus Therapeutics PLC [2014-11-24] 5.39
Baker Bros Advisors LP Celsus Therapeutics PLC [2014-01-06] 13.1
Franklin Resources Inc Celsus Therapeutics PLC [2013-12-10] 17.4
Broadfin Capital LLC Celsus Therapeutics PLC [2013-10-04] 8.9
Sabby Management LLC Celsus Therapeutics PLC [2013-09-24] 6.54
Form 3/4/5 Filer 2011 - 2026
Gaslightwala Abizer
Morria Biopharmaceuticals PLC
Farag Kameel D
Neal James R
Huh Hoyoung
Bazemore Robert B
Prudo-Chlebosz Raymond
Patel Sandip I
Patel Samir Rashmikant
Hombeck Torsten
Hashad Mohamed Wa'el Ahmed
Grissinger Michael
Williams Donald A
Dicicco Wendy F
Jacques Rachelle Suzanne
Cohen Mark S
Ungar Stuart
Williams Donald Allen
Byrne David
Hill James
Shaw Robert M
Shaw Allan
Richardson Clive
RPC Pharma Ltd
Roshwalb Gur
Elefant Dov
Eiran AMOS
Doman Robert F
Sidransky David
Jimenez Pablo
Lau Johnson YIU NAM
Sabby Management LLC
Sabby Healthcare Master Fund Ltd
Mintz Hal
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Neal James R
"Warrants to purchase American Depositary Shares (""ADRs"")" · derivative
2025-12-16 Buy 2,473
Prudo-Chlebosz Raymond
Pre-Funded Warrants to purchase ADRs · derivative
2025-12-16 Buy 618,658 $0.40 247,463
Patel Sandip I
Warrants to purchase ADRs · derivative
2025-12-16 Buy 154,664
Patel Sandip I
Pre-Funded Warrants to purchase ADRs · derivative
2025-12-16 Buy 154,664 $0.40 61,866
Patel Sandip I
"Warrants to purchase American Depositary Shares (""ADRs"")" · derivative
2025-12-16 Buy 247,462
Patel Sandip I
Pre-Funded Warrants to purchase ADRs · derivative
2025-12-16 Buy 247,462 $0.40 98,985
Huh Hoyoung
Warrants to purchase ADRs · derivative
2025-12-16 Buy 3,093,293
Huh Hoyoung
Pre-Funded Warrants to purchase ADRs · derivative
2025-12-16 Buy 3,093,293 $0.40 1,237,317
Huh Hoyoung
Pre-Funded Warrants to purchase ADRs · derivative
2025-12-16 Buy 618,658 $0.40 247,463
Huh Hoyoung
"Warrants to purchase American Depositary Shares (""ADRs"")" · derivative
2025-12-16 Buy 618,658
Farag Kameel D
Pre-Funded Warrants to purchase ADRs · derivative
2025-12-16 Buy 24,745 $0.40 9,898
Farag Kameel D
"Warrants to purchase American Depositary Shares (""ADRs"")" · derivative
2025-12-16 Buy 24,745
Patel Samir Rashmikant
Warrants to purchase ADRs · derivative
2025-12-16 Buy 231,997
Patel Samir Rashmikant
Pre-Funded Warrants to purchase ADRs · derivative
2025-12-16 Buy 618,658 $0.40 247,463
Patel Samir Rashmikant
"Warrants to purchase American Depositary Shares (""ADRs"")" · derivative
2025-12-16 Buy 618,658
Patel Samir Rashmikant
Pre-Funded Warrants to purchase ADRs · derivative
2025-12-16 Buy 231,997 $0.40 92,799
Gaslightwala Abizer
Warrants to purchase ADRs · derivative
2025-12-16 Buy 773,323
Gaslightwala Abizer
"Warrants to purchase American Depositary Shares (""ADRs"")" · derivative
2025-12-16 Buy 309,328
Gaslightwala Abizer
Pre-Funded Warrants to purchase ADRs · derivative
2025-12-16 Buy 309,328 $0.40 123,731
Gaslightwala Abizer
Pre-Funded Warrants to purchase ADRs · derivative
2025-12-16 Buy 773,323 $0.40 309,329
showing 20 of 164 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 1 7,250
2025-12-31 21 4,452,856
2025-09-30 16 1,170,067
2025-06-30 16 550,740
2025-03-31 12 304,398
2024-12-31 15 322,783
2024-09-30 11 181,321
2024-06-30 11 180,188
2024-03-31 9 174,754
2023-12-31 10 285,794
2023-09-30 9 301,133
2023-06-30 17 10,076,550
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com